Two more major pharmaceutical companies to launch products through TrumpRx

The Trump administration said Monday two more major pharmacuetical companies will be launching popular medication on the discounted pharmaceutical site TrumpRx. 

The White House launched the website in February, which is a government-run, direct-to-consumer portal that is considered instrumental in helping the Trump administration lower prescription drug costs in the U.S. 

The companies Abbvie and Genentech are expected to become the 10th and 11th drug-making companies to release their products at a discounted rate on the portal, joining other giants like AstraZeneca, Eli Lilly, Novo Nordisk and Pfizer.  

Abbvie will sell its popular medication Humira, which is used to treat rheumatoid arthritis, Crohn's disease and ulcerative colitis, on the site at an 86% discount, according to CBS News. Genentech will sell its flu-prevention drug Xofluza.

The Humira pen is now expected to cost uninsured Americans $950, down from as high as $6,900, and a prescription of Xofluza will cost $50 instead of $168, the outlet reported.

The new additions will bring the total up to 61 drugs that the website now offers at a discounted price. TrumpRx offered discounted prices for 40 of the most popular and expensive medications in the country, including Ozempic and Wegovy, which help treat diabetes, heart disease and obesity, at its launch.

Misty Severi is a news reporter for Just The News. You can follow her on X for more coverage.